Cabaletta Bio, Inc. · NASDAQ:CABA

Bain Capital Life Sciences Opportunities III, LP reported a 9.57% stake in Cabaletta Bio, Inc. (Schedule 13G/A)

Event Sep 30, 2026 · Filed Nov 16, 2026

Bain Capital Life Sciences Opportunities III, LP reported a 9.57% stake in Cabaletta Bio, Inc., 21,209,188 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).

Stake
9.57%
Shares
21,209,188
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
Bain Capital Life Sciences Opportunities III, LP9.57%21,209,188

Source

Download original · View original at SEC

Related